# Saponins from Oxybasis rubra (L.) S.Fuentes, Uotila & Borsh: Comparative Assessment of Cytotoxic Potential Against a Wide Panel of Cancer Cell Lines

**Authors:** Karolina Grabowska, Adam Mynarski, Agnieszka Galanty, Dagmara Wróbel-Biedrawa, Paweł Żmudzki, Irma Podolak

PMC · DOI: 10.3390/molecules30153126 · 2025-07-25

## TL;DR

This study isolates and evaluates saponins from Oxybasis rubra, finding one compound with strong cancer cell toxicity and low impact on normal cells.

## Contribution

A novel monodesmoside hederagenin glucoside and its cytotoxic profile against diverse cancer cell lines are reported.

## Key findings

- Compound 2 showed the strongest activity with an IC50 of 6.52 μg/mL against WM793 melanoma cells.
- Compound 2 had minimal effect on normal HaCaT skin cells (IC50 = 39.94 μg/mL).
- PCA and HCA confirmed that cytotoxicity depends on compound type, concentration, and cell line sensitivity.

## Abstract

Two triterpene saponins, hederagenin glucosides, including a novel monodesmoside: 3-O-β-D-glucopyranosyl(1→3)-β-D-glucopyranosyl] hederagenin (compound 1), were isolated from the fruits of Oxybasis rubra (L.) S.Fuentes, Uotila & Borsh (Amaranthaceae). These compounds, together with hederagenin itself (compound 4) and a commercially available 28-O-β-D-glucopyranosyl hederagenin ester (compound 3), were evaluated for cytotoxicity and selectivity across a wide panel of human cancer cell lines (skin, prostate, gastrointestinal, thyroid, and lung). All four compounds exhibited dose- and time-dependent effects, with varying potency depending on the specific cancer type. The isolated bidesmosidic saponin (3-O-β-D-glucopyranosyl(1→3)-β-D-glucopyranosyl] hederagenin 28-O-β-D-glucopyranosyl ester—compound 2) showed the strongest activity and selectivity, with an IC50 = 6.52 μg/mL after 48 h incubation against WM793 melanoma, and almost no effect on normal HaCaT skin cells (IC50 = 39.94 μg/mL). Multivariate analysis of the obtained data using principal component analysis (PCA) and hierarchical cluster analysis (HCA) supported the assumption that cytotoxicity is influenced by the type of compound, its concentration, and the intrinsic sensitivity of the cell line. Structure-activity observations between closely related hederagenin derivatives are also briefly presented.

## Linked entities

- **Chemicals:** hederagenin (PubChem CID 73299)
- **Diseases:** melanoma (MONDO:0005105)
- **Species:** Oxybasis rubra (taxon 3560)

## Full-text entities

- **Diseases:** cytotoxicity (MESH:D064420), Cancer (MESH:D009369), melanoma (MESH:D008545)
- **Chemicals:** 28-O-beta-D-glucopyranosyl hederagenin ester (-), Saponins (MESH:D012503), hederagenin (MESH:C025763)
- **Species:** Homo sapiens (human, species) [taxon 9606], Oxybasis rubra (pigweed, species) [taxon 3560]
- **Cell lines:** WM793 — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_8787), HaCaT — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0038)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12348107/full.md

---
Source: https://tomesphere.com/paper/PMC12348107